Carey Ng insider trades
Open-market stock purchases and sales by Carey Ng, Director at Immix Biopharma, Inc, from SEC Form 4 filings since Dec 20, 2021.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +146%.
Companies traded
- IMMX Immix Biopharma, Inc: 3 buys, last May 22, 2026